TARO
Taro Pharmaceutical Industries Ltd.
TARO
TARO
Delisted
TARO was delisted on the 21st of June, 2024.
127 hedge funds and large institutions have $521M invested in Taro Pharmaceutical Industries Ltd. in 2017 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 27 increasing their positions, 44 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
39% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 44
87% less call options, than puts
Call options by funds: $280K | Put options by funds: $2.15M
Holders
127
Holding in Top 10
2
Calls
$280K
Puts
$2.15M
Top Buyers
| 1 | +$16.1M | |
| 2 | +$11.1M | |
| 3 | +$10.7M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$8.6M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.99M |
Top Sellers
| 1 | -$51.1M | |
| 2 | -$21.6M | |
| 3 | -$20.8M | |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
-$14.2M |
| 5 |
Goldman Sachs
New York
|
-$7.09M |